Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.720
+0.170 (3.74%)
May 28, 2026, 3:27 PM EDT - Market open
Atea Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Atea Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $8.67. The average 1-year stock price forecast is 83.69% higher than the current stock price, while the lowest is $6.00 (+27.12%) and the highest is $10 (+111.86%).
Price Target: $8.67 (+83.69%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Atea Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $6 → $4.1 | Hold | Maintains | $6 → $4.1 | -13.14% | May 18, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 13, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $6 → $10 | Buy | Maintains | $6 → $10 | +111.86% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
30.77M
EPS This Year
-1.69
from -1.94
EPS Next Year
-1.69
from -1.69
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 63.4M | |
| Avg | n/a | 30.8M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.74 | -1.74 | |
| Avg | -1.69 | -1.69 | |
| Low | -1.63 | -1.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.